In Australia, these 15 heavily pretreated patients would have been offered palliative care only.
So the response rate would have been 0/15.
Is that any good?
- Forums
- ASX - By Stock
- RAC
- Ann: Impressive Bisantrene Phase 2 AML Clinical Results
Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-46
-
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.55 |
Change
0.025(1.64%) |
Mkt cap ! $264.2M |
Open | High | Low | Value | Volume |
$1.53 | $1.58 | $1.53 | $6.491K | 4.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5540 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 37690 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5540 | 1.530 |
2 | 1387 | 1.525 |
3 | 2167 | 1.520 |
2 | 677 | 1.515 |
1 | 16 | 1.510 |
Price($) | Vol. | No. |
---|---|---|
1.570 | 37690 | 1 |
1.580 | 10578 | 2 |
1.585 | 141 | 1 |
1.610 | 300 | 1 |
1.620 | 2192 | 2 |
Last trade - 10.43am 12/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online